Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Fractional Nonablative 1540 nm Laser Resurfacing for Burn Scars- A Randomised Controlled Trial

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2008 by Bispebjerg Hospital.
Recruitment status was  Active, not recruiting
Information provided by:
Bispebjerg Hospital Identifier:
First received: May 30, 2008
Last updated: NA
Last verified: May 2008
History: No changes posted
The objective was to evaluate the efficacy of 1540 nm fractional laser treatment of mature burn scars.

Condition Intervention
Burn Scar Patients
Device: 1540 nm fractional laser

Study Type: Interventional
Official Title: Fractional Nonablative 1540 nm Laser Resurfacing for Burn Scars- A Randomised Controlled Trial

Resource links provided by NLM:

Further study details as provided by Bispebjerg Hospital:

Primary Outcome Measures:
  • Change of skin texture from baseline

Study Start Date: November 2007
Arms Assigned Interventions
Experimental: A Device: 1540 nm fractional laser
No Intervention: B


Ages Eligible for Study:   18 Years to 60 Years   (Adult)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Burn scars with and without previous skin grafting.

Exclusion Criteria:

  • A tendency to produce hypertrophic scars or keloids,
  • Previous treatment with dermabrasio, chemical peel, filler, laser treatment or Intense Pulsed Light (IPL) of study areas,
  • Photosensitivity,
  • Pregnancy or lactation,
  • Current anticoagulative medication,
  • Oral retinoid drugs within the past 6 months,
  • Pigmentation after recent exposure to sun or solarium,
  • Patients not considered to be able to follow the treatment protocol.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00689650

Bispebjerg University Hospital
Copenhagen NV, Denmark, 2400
Sponsors and Collaborators
Bispebjerg Hospital
  More Information Identifier: NCT00689650     History of Changes
Other Study ID Numbers: H-D-2007-0094 
Study First Received: May 30, 2008
Last Updated: May 30, 2008
Health Authority: Denmark: Ministry of Health

Additional relevant MeSH terms:
Wounds and Injuries
Pathologic Processes processed this record on October 21, 2016